EAN 2026: Infection Risk Across Multiple Sclerosis Therapies – Insights from a Danish Nationwide Study
At EAN 2026, Rolf Pringler Holm, postdoc at the Danish Multiple Sclerosis Registry, presented findings from a nationwide registry study showing how disease-modifying therapies influence infection risk in multiple sclerosis and how machine learning may help identify high-risk patients.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
